$GANX

$1.17 +$0.02 (1.74%) Close

$GANX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$GANX Management Team

Mr. Khalid Islam

Chairman of the Board

Founder

Age 69

Compensation $84.51K USD

Sex Male

Mr. Gene Mack

President

Chief Executive Officer

Director

Age 51

Compensation $737.7K USD

Sex Male

Mr. Gianluca Fuggetta

Senior Vice President - Finance

Principal Financial Officer

Age 36

Compensation $367.9K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Khalid Islam Chairman of the Board Founder	69	$84.51K USD	Male
Mr. Gene Mack President Chief Executive Officer Director	51	$737.7K USD	Male
Mr. Gianluca Fuggetta Senior Vice President - Finance Principal Financial Officer	36	$367.9K USD	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

5 of 7

stated in the proxy

Average tenure

5.3 years

from year joined

CEO also chairs the board

Khalid Islam

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Gene Mack CEO	52	2025 1 year	Not independent	None stated	None stated	Paid as CEO
Khalid Islam Board chair	70	2017 9 years	Not independent	None stated	Fennec Pharmaceuticals Inc., Minoryx Therapeutics S.L.	Not stated
Dov Goldstein	58	2021 5 years	Independent	None stated	Coya Therapeutics, Inc.	$80,150
Hans Peter Hasler	70	2021 5 years	Independent	None stated	HBM Healthcare Investments AG, Minerva Neuroscience Inc., Shield Therapeutics PLC	$76,650
Gwen Melincoff	74	2021 5 years	Independent	None stated	Protalix Biotherapeutics, Inc.	$63,150
Claude Nicaise	73	2021 5 years	Independent	None stated	Sarepta Therapeutics, Inc., Chemomab Therapeutics Ltd, Cassava Sciences, Inc.	$68,150
Jeffrey Riley	63	2019 7 years	Independent	None stated	None stated	$78,650

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 28, 2026

Matthias Alder

former Chief Executive Officer

$525,000

2024

Separation agreement with former CEO providing severance payment of twelve months base salary, COBRA premium payments, partial equity vesting, and continued insurance premiums.

Open in proxy

Minoryx Therapeutics, S.L.

Dr. Islam, one of our founders and Chairman of our Board, is the chairman of the board of directors of Minoryx

Amount not stated

2024 and 2025

License agreement under which the company licensed intellectual property from Minoryx and agreed to pay royalties; no payments were made in 2025 or 2024.

With Minoryx Therapeutics, S.L. Open in proxy

Comments

Company Executives

$GANX Management Team

Mr. Khalid Islam

Mr. Gene Mack

Mr. Gianluca Fuggetta

Board of Directors

Related-party transactions